LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators 2023, ' Intravenous Vitamin C for Patients Hospitalized With COVID-19 : Two Harmonized Randomized Clinical Trials ', JAMA, vol. 330, no. 18, pp. 1745-1759 . https://doi.org/10.1001/jama.2023.21407 Jama : Journal of the American Medical Association, 330, 18, pp. 1745-1759 Adhikari, N K J, Hashmi, M, Tirupakuzhi Vijayaraghavan, B K, Haniffa, R, Beane, A, Webb, S A, Angus, D C, Gordon, A C, Cook, D J, Guyatt, G H, Berry, L R, Lorenzi, E, Mouncey, P R, Au, C, Pinto, R, Ménard, J, Sprague, S, Masse, M-H, Huang, D T, Heyland, D K, Nichol, A D, McArthur, C J, de Man, A, Al-Beidh, F, Annane, D, Anstey, M, Arabi, Y M, Battista, M-C, Berry, S, Bhimani, Z, Bonten, M J M, Bradbury, C A, Brant, E B, Brunkhorst, F M, Burrell, A, Buxton, M, Cecconi, M, Cheng, A C, Cohen, D, Cove, M E, Day, A G, Derde, L P G, Detry, M A, Estcourt, L J, Fagbodun, E O, Fitzgerald, M, Goossens, H, Green, C, Higgins, A M, McAuley, D F & LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators 2023, ' Intravenous vitamin C for patients hospitalized with COVID-19. Two harmonized randomized clinical trials ', JAMA: Journal of the American Medical Association . https://doi.org/10.1001/jama.2023.21407 Neill K. J., N K J A, Lamontagne, F & Bradbury, C A 2023, ' Intravenous Vitamin C for Patients Hospitalized with COVID-19 : Two Harmonized Randomized Clinical Trials ', JAMA-Journal of the American Medical Association, vol. 330, no. 18, pp. 1745-1759 . https://doi.org/10.1001/jama.2023.21407 LOVIT-COVID Investigators, Canadian Critical Care Trials Group, REMAP-CAP Investigators & Dark, P 2023, ' Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials ', JAMA, vol. 330, no. 18, pp. 1745-1759 . https://doi.org/10.1001/jama.2023.21407 JAMA
Intensive Care Med INTENSIVE CARE MEDICINE the REMAP-CAP Investigators 2021, ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19 : REMAP-CAP randomized controlled trial ', Intensive Care Medicine, vol. 47, no. 8, pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5 Intensive Care Medicine, 47, 8, pp. 867-886 Intensive care medicine Arabi, Y M 2021, ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19 : REMAP-CAP randomized controlled trial ', Intensive Care Medicine, vol. 47, no. 8, pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5 2021, ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19 : REMAP-CAP randomized controlled trial ', Intensive Care Medicine, vol. 47, no. 8, pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5 Intensive Care Medicine Intensive Care Medicine, 2021, 47 (8), pp.867-886. ⟨10.1007/s00134-021-06448-5⟩ Investigators, REMAP-CAP & Dark, P 2021, ' Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. ', Intensive care medicine, vol. 47, no. 8, pp. 867-886 . https://doi.org/10.1007/s00134-021-06448-5 Intensive Care Medicine, vol 47, iss 8
Lancet LANCET Linden, D, McGarvey, L & RECOVERY Collaborative Group 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) a randomised controlled, open-label, platform trial ', The Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Mumford, A D 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial ', Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Group, RECOVERY C, Dark, P & Hughes, G 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. ', Lancet (London, England), vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7
Jama : Journal of the American Medical Association, 329, 14, pp. 1183-1196 JAMA : the journal of the American Medical Association Lawler, P R, Derde, L P G, Van De Veerdonk, F L, McVerry, B J, Huang, D T, Berry, L R, Lorenzi, E, Van Kimmenade, R, Gommans, F, Vaduganathan, M, Leaf, D E, Baron, R M, Kim, E Y, Frankfurter, C, Epelmaņ, S, Kwan, Y, Grieve, R, O'Neill, S, Sadique, Z, Puskarich, M, Marshall, J C, Higgins, A M, Mouncey, P R, Rowan, K M, Al-Beidh, F, Annane, D, Arabi, Y M, Au, C, Beane, A, Van Bentum-Puijk, W, Bonten, M J M, Bradbury, C A, Brunkhorst, F M, Burrell, A, Buzgau, A, Buxton, M, Cecconi, M, Cheng, A C, Cove, M, Detry, M A, Estcourt, L J, Ezekowitz, J, Fitzgerald, M, Gattas, D, Godoy, L C, Goossens, H, Haniffa, R, Harrison, D A, Hills, T, Horvat, C M, Ichihara, N, Lamontagne, F, Linstrum, K M, McAuley, D F, McGlothlin, A, McGuinness, S P, McQuilten, Z, Murthy, S, Nichol, A D, Owen, D R J, Parke, R L, Parker, J C, Pollock, K M, Reyes, L F, Saito, H, Santos, M S, Saunders, C T, Seymour, C W, Shankar-Hari, M, Singh, V, Turgeon, A F, Turner, A M, Zarychanski, R, Green, C, Lewis, R J, Angus, D C, Berry, S, Gordon, A C, McArthur, C J & Webb, S A 2023, ' Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with Covid-19. A randomized clinical trial ', JAMA, vol. 329, no. 14, pp. 1183-1196 . https://doi.org/10.1001/jama.2023.4480 Investigators, W C F T REMAP-CAP & Dark, P 2023, ' Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. ', JAMA . https://doi.org/10.1001/jama.2023.4480 JAMA